Tagungen und Workshops zum Thema Onkologie

This conference will focus on three major areas: First, it will present new approaches to generate precise and complex genetic alterations in mice and other animals to better “humanize” models and allow for in vivo studies of cancer gene function. Second, it will highlight studies to investigate fundamental mechanisms of cancer initiation and progression, including the cell of origin of tumors, their evolution, their metabolism, and their interactions with the immune system. Finally, the meeting will explore how genetically engineered animal models can help evaluate the efficacy of novel therapeutic approaches and to decipher mechanisms of therapeutic resistance.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

New technologies for cancer modelling, Modeling pre-cancers and tumor initiation, Cancer metabolism, Cancer/immune interactions and tumor microenvironment, Metastasis, Preclinical trials and resistance, Oncology, Animal Modeling

Biologie,    Translationale Medizin, Klinische Studien

Van Andel Institute

Origins of Cancer is a one-day symposium that brings together students, scientists and medical professionals to discuss the latest breakthroughs in cancer research. This year’s meeting will highlight the tumor macroenvironment, which comprises near and far cells, tissues and systems that interact with primary cancer cells to promote tumor survival. Invited speakers also will discuss novel and integrative treatment approaches that target this larger interactome to outsmart cancer cells.

Email: beth.resau@vai.org

Cancer, Biology, Immuno-oncology, Tumor microenvironment, metabolism, Exosomes, Cancer Therapeutics,

European Association for Cancer Research & European Society of Oncologic Imaging

This new conference is organised by the European Association for Cancer Research (EACR) and the European Society of Oncologic Imaging (ESOI).Our ability to understand and treat cancer is critically dependent upon imaging. This meeting will bring together imaging experts in both clinical and basic research arenas to present their latest research and discuss how to integrate understanding across length scales, imaging modalities, and cancer types. Improved clinical imaging has the power to transform the detection and biologic characterisation of early lesions and the identification of those patients with more advanced disease for tailoring and monitoring personalised therapies. Further, the development of new therapies depends on improved understanding of cancer biology; small animal imaging and imaging tumours with cellular and sub-cellular resolution can elucidate heterogeneity in cancer cell state and interactions with stromal cells, which provide new opportunities for therapeutic intervention. This conference is aimed at clinical and experimental cancer researchers working with, or interested in, the broad range of imaging modalities including US and photoacoustic, CT and micro CT, MRI, PET/CT and PET/MR hybrid imaging, as well as optical techniques. Data analysts dealing with imaging data science using deep learning/machine learning, are also explicitly encouraged to attend.

Email: claire.sullivan@eacr.org

Imaging, Oncology, Machine Learning, Deep Learning, Cancer Biology, Personalised Therapies

The eighth annual meeting of the Society of Hematologic Oncology (SOHO 2020) is scheduled for September 9–12, 2020 at the Hilton Americas, 1600 Lamar St, Houston, Texas 77010. Organized by its founders and world class committees, SOHO is the only international society specific to the field of hematologic malignancies.

Tel.: [+4936413116390];     Email: conferencemarketing@conventus.de

Liquid biopsies have the advantage of being largely non-invasive and providing a vast amount of information for the detection and monitoring of diseases such as cancer. This course will provide hands-on experience in the several techniques to detect and analyse circulating tumor cells (CTCs), cell free tumor DNA (ctDNA) and proteins. Participants will have the opportunity to learn all aspects ranging from proper sampling through error free sequencing to data analysis. Lectures will also cover extracellular vesicles and clinical aspects using liquid biopsies, especially in the field of cancer diagnostics.

EMBL Events;     Tel.: [+49 6221 378 8797];     Email: events@embl.de

Hands-on experience on ultra-sensitive mutation detection using sequencing, Applications of digital PCR to the liquid biopsy workflow, Protein analysis in liquid biopsis, Data analysis and interpretations

Medizin (allgem.),    Analysis

Tel.: [+4936413116390];     Email: conferencemarketing@conventus.de

We are delighted to invite you to participate in the 3rd Annual Meeting of the International Academy for Clinical Hematology (IACH): Focus on Leukemia, taking place October 1-3, 2020 in Nice, France.Our 3rd edition will focus on leukemia in a format that allocates a significant amount of time to interactive debates and audience questions to the expert panels. Participants are encouraged to take an active role in the discussions with faculty members in this unique open environment.

Tel.: [+972528887612];     Email: moran@cme-congresses.com

Leukemia, CAR T Cell therapy

Hämatologie,    Stammzellforschung und -therapie

The Royal Marsden

The 2nd EACR Conference on Mechanisms to Therapies: Innovations in Cancer Metabolism will gather top experts in the field to discuss the metabolic alterations in tumours and how we can exploit it to treat cancer.

Email: laura.strachan@eacr.org

Deutsche Gesellschaft für Neuroradiologie e.V.

Das Motto des neuroRAD 2020 Neue Arbeitswelten transportiert etwas von dem enormen gesellschaftlichen Wandel, in dem Ärztinnen und Ärzte wirken.

Kongress- und Kulturmanagement GmbH;     Tel.: [+49 3643 2468 157];     Email: antje.sauter@kukm.de

Neuroradiologie, Interventionelle Neuroradiologie, Neuroonkologie, Neurodegenerative Erkrankungen

The purpose of the International Symposium on Mathematical and Computational Oncology (ISMCO) is to provide a common interdisciplinary forum for mathematicians, scientists, engineers and clinical oncologists to present and discuss the latest research findings, ideas, developments and applications in mathematical and computational oncology. In particular, ISMCO aspires to enable the forging of stronger relationships among mathematics and physical sciences, computer science, data science, engineering and oncology with the goal of developing new insights into the pathogenesis and treatment of malignancies. The symposium will consist of invited and contributed presentations (oral and poster) dealing with all aspects of mathematical and computational oncology. There will also be several keynote presentations, tutorials, special tracks, and panel discussions.

Publicity Chair;     Email: jpetereit@unr.edu

cancer, big data, ML, computer vision, high-throughput, systems biology, interdisciplinary, HPC, precision medicine

EHOC 2020 will fill in a significant gap in our region and serve not only scientifically but also culturally.

EORTC, European Organisation for Research and Treatment of Cancer, Brussels

ENA 2020 is the drug development and translational research meeting, focusing on preclinical and phase I studies, enabling and facilitating in-depth scientific discussions on the latest developments in targets and drugs.

Attracting academics, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.

Event Seretariat;     Email: ena@eortc.org

Cancer research, clinical research, molecular biology, targeted therapies

United Research Forum

The United Research Forum is honored to invites the leading academic Scientists, Researchers, Engineers, Research Scholars, Academic Professors and Students to participate at “International Conference on Cancer Science and Therapy” during 29-30 of October, 2020 at The Manchester University, UK.

Tel.: [07424263073];     Email: iccst@manchestercancer.uk

Cancer 2020, Cancer Summit 2020, Cancer Events Europe, Cancer Conference 2020, Oncology Conferences 2020, Chemotherapy Conferences, COVID-19 Conferences, Cancer Conferences UK, Oncology Conferences UK, Cancer Conference Manchester

Chirurgie,    Nuklearmedizin und Radiotherapie

Bioevents

Tel.: [00442030514032 x 525];     Email: ilana@bioevents-congress.com

Leukemia, hematology, stem cells, Myeloid Malignancies, malignancy, oncology, cancer, blood, AML, diagnosis, Immunotherapy in AML, Immunotherapy, CML, Controversies in CML, Biology of Leukemias, CLL, ALL, Leukemia stem cells (LSCs), LSC, Allogeneic hematopoietic

Melton Medical Education, LLC

Over the past two decades, this meeting has become the premier forum for discussion of the diagnosis and treatment of myeloproliferative neoplasms (MPNs), providing timely, relevant and meaningful information to attendees from around the world.

Tel.: [5126195534];     Email: info@meltonmeded.com

myeloproliferative neoplasm, MPN, PV, CML, ET, Mastocytosis, CMMol, thrombocytosis, hematopoiesis, Hypereosinophilias, MF, myelofibrosis, JAK2, CME, NY, Silver

Fortbildung für Gesundheitsfachberufe (CME),    Hämatologie

Biotexcel

Genomic Medicine Nordic Conference is an annual event organized by Biotexcel in partnership with Odense University Hospital and the Kennedy Centre at Rigshospitalet. This year, the Nordic conference will take place in Odense and, as always, it will focus on high throughput genomic technologies with a special focus on Next Generation Sequencing in the research and clinical analysis of human disease. As our contingent of loyal and returning delegates will be aware, the scientific theme will cover advances in the following areas: Genomics, Next Generation Sequencing Applications and Workflows, Personalized Genomics, the Metagenomics link to health/disease, Non-invasive Prenatal testing (NIPT), Cancer and Rare Disease genetics as well as Data Analysis and Storage and many more emerging research applications as well as their translation into their clinic. As always, in addition to the scientific program, our conference will also organize specific networking events which will allow delegates to interact with each other and engage in scientific discussions.

Biotexcel;     Email: genmednordic@biotexcel.com

NGS, DNA, bioinformatics, biology, genetics, genomics, diagnostics, proteomics, biomarkers, computational biology, data analysis, data interpretation, DNA sequencing, disease, genetic disease, informatics, molecular biology, cell biology, molecular diagnostics, event, conference, speakers, education, lecture, science, genes, medicine, technology

ESOI (European Society of Oncologic Imaging)

The ESOI/EORTC workshop is an interactive hands-on course aimed at practising radiologists and radiology residents, focusing on the criteria-based assessment of tumour response to treatment. The course consists of a number of lectures explaining the principles of imaging-based tumour response assessment and several hands-on interactive training workshops using specialised software with common and rare cancer cases encountered in the clinical routine or within clinical trials.

ESOI Office;     Tel.: [+4315334064924];     Email: office@esoi-society.org

Radiologie (allgem.),    Fortbildung für Gesundheitsfachberufe (CME)

Fraunhofer Institute for Cell Therapy and Immunology IZI and the University Cancer Center of the University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. This year’s conference will focus on tumor microenvironment, cell-based therapy in hematology and oncology, immune checkpoint inhibitors, biomarkers, cell therapies and cancer vaccines.

Fraunhofer Institute for Cell Therapy and Immunology;     Tel.: [+49 341 35536-9320];     Email: info@lion-conference.com

oncology, immunology, hematology, biomarkers, immunotherapy, cell therapies, cancer vaccines

Immunologie und Allergie,    Hämatologie

The New Zealand Association of Breast Cancer Research Incorporated (NZABC® Inc.)

The New Zealand Association of Breast Cancer Research Incorporated (NZABC® Inc.) is organising the second New Zealand Breast Cancer Symposium in 2020 (NZBCS-2020), which will be held in Auckland, New Zealand from 12-14th November 2020.

Chair, the Organising Committee of NZBCS-2020;     Tel.: [0064-9-921 9999];     Email: nzbcs@aut.ac.nz

Breast Cancer, New Zealand, NZBCS, NZBCS-2020, NZABCR, Auckland, Symposium, Biomarker, Targeted Therapy, Immunotherapy

European Association for Cancer Research

This meeting aims to develop our understanding of the potential of liquid biopsies. This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse. It will also explore how liquid biopsies can be incorporated in cancer patient management and how implementation of liquid biopsies can change clinical practice.

Email: claire.sullivan@eacr.org

Liquid Biopsies, Biopsies, Tumor cells, Early detection of cancer, nucleic acids, biomarkers

University of Kansas Medical Center, Office of Continuing Education and Professional Development

Our 2020 Hematology and Medical Oncology Review aims to disseminate state-of-the-art information from several major national meetings that have occurred within the last year including the Annual Meeting of the American Society of Clinical Oncology (ASCO), The San Antonio Breast Cancer Symposium (SABC) and the American Society of Hematology Review (ASH). Nationally and internationally known speakers will discuss crucial data with healthcare professionals treating and managing patients regarding hematological malignancies and the management of breast, lung, head and neck, gastrointestinal and genitourinary cancers.

Contact CE;     Tel.: [913-588-4488];     Email: Contactce@kumc.edu

Hematology, Medical Oncology, American Society of Clinical Oncology (ASCO), The San Antonio Breast Cancer Symposium (SABC), The American Society of Hematology Review (ASH)

Deutsche Krebsgesellschaft e.V. (DKG), Arbeitsgemeinschaft Dermatologische Onkologie (ADO)

Die Checkpoint-Blockade hat sich aufgrund ihrer Effizienz in der Therapie vieler Tumorentitäten etabliert. Gleichzeitig stellt sie uns vor neue Herausforderungen. Durch den Eingriff in das Immunsystem kann es zu Entzündungen kommen, die diagnostisch und therapeutisch Probleme darstellen können und oft ein interdisziplinäres Netzwerk erfordern. In dieser Veranstaltung wollen wir die Diagnostik und Therapie solcher „immune-related“ Nebenwirkungen - unabhängig von der zugrunde liegenden Indikation oder Substanz - für die einzelnen Organsysteme durchgehen und mit Experten diskutieren.

Kontakt Nationale Gesundheits-AKADEMIE NGA GmbH;     Tel.: [+49 (0) 3643 2468-31];     Email: info@ng-akademie.de

Immunonkologie, Onkologie, Dermatologie, Checkpoint-Blockade, Immuntherapie, „immune-related“ Nebenwirkungen, irAE, Endokrinologie, Pneumologie, Rheumatologie, Neurologie, Nebenwirkungsregister SERIO, Nephrologie, Gastroenterologie, Hepatologie, Kardiologie, Hämatologie, Dermatologie, Fertilitätserhaltung, Systemtherapie

Dermatologie,    Neurologie

European Association for Cancer Research

Following the highly successful first and second edition, Defence is the Best Attack 2021 will be the third EACR conference on this topic. In this conference, we will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Laura Strachan;     Email: laura.strachan@eacr.org

immunotherapy, immuno-oncology, biomarkers, Vaccination

The British Institute of Radiology

This is an inaugural meeting for the BIR, which brings together speakers from around the world and national experts too, to share experiences and expertise in a very wide range of aspects for today’s cutting-edge radiotherapy and oncology. The latest techniques, technologies, methods and issues will be discussed in this comprehensive meeting taking place over two days. Opportunities aplenty for networking with fellow professionals and discussing the latest offerings from manufacturers.

Events team;     Tel.: [02036682220];     Email: conference@bir.org.uk

Particle therapy, MR guided radiotherapy, Hypofractionation, AI / Machine learning / Big data, Adaptive therapy, Clinical trials, Strategic, policy and workforce issues, Radiotherapy errors and challenges, Engineering / IT / Infrastructure, Manufacturers presentations

Tel.: [+4936413116390];     Email: julia.wrenczycki@conventus.de

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email: conferencemarketing@conventus.de